Delhi Delhi: According to a new study, antibiotic used to treat infectious diarrhea can be an effective drug for a type of inflammatory bowel disease.

U.K. Researchers at the University of Birmingham showed that an antibiotic called vancomisin can also be effective in treating people who have a specific type of inflammatory intestinal disease (IBD), which is a incurable scalarousing colangitis (PSC) a incurable autoimmune liver disease The cause develops.

In particular, four of the five patients participating in the study were exempted after taking the drug as part of a clinical test published in the Journal of Crohn and Colitis. This study is important, because the study is important, because suffering from this disease Many participants did not react to other IBD remedies. In addition, IBD and PSC have a deep connection with each other, IBD develops in most individuals suffering from PSC, and PSC also develops in 14 percent of patients suffering from IBD.

Together, this condition enhanced the need for colon surgery and development of colon or liver cancer, for which they would need a liver transplant. This also increases the overall risk of death. Dr. Mohammad Nabil Qureshi of the University of Birmingham said, “Our findings suggest that vancomisin IBD and autoimmune can provide a new therapeutic option for patients with this challenging combination of liver disease.” During the test, participants were treated with oral antibiotics for four weeks. About 80 percent of the patients received clinical discounts after treatment. He also showed a significant decrease in signs of inflammation, and 100 percent showed mucosal treatment. However, when treatment was stopped after 8 weeks, the symptoms came back. Vancomisin was also shown to change some bile acids, which is now being investigated further to develop and refine treatment for IBD- PSC. Although the results are initial, they provide a strong base for further research, the team said.